-
Nagi Bioscience among the TOP 100 Swiss Startups 2022
We are proud to announce that Nagi Bioscience has entered the distinguished TOP 100 Swiss Start Up 2022 ranking under the biotech category.
-
SydLab Analyzer: The end of manual worm counting
A unique data processing pipeline using a unique AI-based software for C.elegans assays.
-
Alternative Testing Market Overview
The animal testing market loses the battle of growth against non-animal technologies.
-
High-Content Screening technologies and drug development
We called our SydLab System a high-content screening technology many times, but what does it mean exactly?
-
European Worm Meeting – Together for the C. elegans community
Nagi & MolGen in tandem at the European Worm Meeting 2022 at booth #5
-
Microfluidic Chips: Exploring the technology
Exploring the advantages of microfluidic chips for biological experiments.
-
Lab Automation: In search for efficiency
The quest for efficiency does not distinguish between industries. And labs are no exception. But, what does it implies to automate your lab?
-
A new approach to replace animal testing
Our CEO and co-founder, Matteo Cornaglia, speaks today about the future of New Approach Methodologies and how Nagi Bioscience is fulfilling this market need in an interview for Verve Ventures.
-
The future of drug and substance testing is ethical
The US House of Representatives passed the FDA Modernization Act to transform the drug approval process and move towards a non-animal testing future.
-
Nagi Bioscience and the future of labs
Meet the Organism-on-Chip that is revolutionizing the biotech sector in Nagi’s booth at Future Labs Live in Basel.